MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617058183 A) filed by Shenzhen Targetrx Co. , Ltd. on May 07, 2026, for Method For Treating Leukemia.
Inventors include Wang, Yihan; Cao, Jingrong Number; Shi, Yanxia; Liu, Yun; and Zhao, Jiuyang.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: Provided is a method for treating chronic-phase and/or accelerated-phase and/or blast-phase chronic myelogenous leukemia and/or acute lymphoblastic leukemia in a subject by administering to the subject a compound of formula (I) or a pharmaceutically acceptable salt, crystal form, solvate or hydrate thereof. Also provided is a use of the compound of formula (I) or the pharmaceutically acceptable salt, crystal form, solvate or hydrate thereof in combination with an ATP-competitive BCR-ABL1 inhibitor.
Disclaimer: Curated by HT Syndication.
